<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02949739</url>
  </required_header>
  <id_info>
    <org_study_id>16SM3246</org_study_id>
    <nct_id>NCT02949739</nct_id>
  </id_info>
  <brief_title>Prevention of Type 2 Diabetes Amongst South Asians With Central Obesity and Prediabetes</brief_title>
  <acronym>iHealth-T2D</acronym>
  <official_title>Lifestyle Intervention to Prevent Type 2 Diabetes Amongst South Asians With Central Obesity and Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>London North West Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators' general goal is to identify approaches to risk stratification and health&#xD;
      promotion through lifestyle modification that are acceptable, effective and efficient for&#xD;
      prevention of T2D in South Asian communities from diverse settings.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific aims of the proposed iHealth-T2D study are:&#xD;
&#xD;
        1. Determine whether intensive lifestyle modification vs usual care reduces risk of T2D&#xD;
           (primary endpoint) amongst South Asians with i. central obesity; ii. prediabetes and&#xD;
           iii. overall (with central obesity and / or obesity).&#xD;
&#xD;
        2. Investigate secondary endpoints, including health gains in family members. Identify&#xD;
           social, demographic and environmental factors influencing primary and secondary&#xD;
           endpoints.&#xD;
&#xD;
        3. Carry out a health economic analysis of lifestyle modifications vs usual care for&#xD;
           prevention of T2D on the Indian subcontinent and Europe. Quantify the cost-effectiveness&#xD;
           of screening by waist circumference vs HbA1c.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Actual">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>&gt;7% reduction in weight</measure>
    <time_frame>4 year</time_frame>
    <description>The investigators aim to achieve this outcome by motivating study participants to improve diet habits and increase physical activity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of ≥5 cm waist circumference</measure>
    <time_frame>4 year</time_frame>
    <description>The investigators aim to motivate the participants to adopt a healthier lifestyle in order to achieve at least 5cm waist circumference reduction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5244</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Intensive lifestyle modification</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The investigators will recruit 3,600 South Asian men and women aged 40-70 years with i. central obesity (waist≥100 cm) and/or ii. prediabetes (HbA1c 6.0-6.4%) to the study (Index cases). Recruitment will be from the Indian subcontinent (India, Pakistan, Sri Lanka) and Europe (UK). Index cases will receive either i. intensive lifestyle modification (N=1,800); or ii. usual care (N=1,800).&#xD;
Intensive lifestyle modification follows clinically accepted, evidence based strategies to achieve &gt;7% reduction in weight through improved diet and increased physical activity, and is delivered as 9 face-face and 13 telephone contact sessions over 12 months.&#xD;
Index cases will be followed for three years to identify new-onset T2D.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The investigators will recruit 3,600 South Asian men and women aged 40-70 years with i. central obesity (waist≥100 cm) and/or ii. prediabetes (HbA1c 6.0-6.4%) to the study.&#xD;
Recruitment will be from the Indian subcontinent (India, Pakistan, Sri Lanka) and Europe (UK). Index cases will receive either i. intensive lifestyle modification (N=1,800); or ii. usual care (N=1,800).&#xD;
Usual care group will comprise one diabetes prevention session and written material.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intensive lifestyle modification</intervention_name>
    <description>The intervention is delivered as 9 face-face and 13 telephone contact sessions over 12 months. Index cases are the focus for the intervention, but lifestyle modification encourages the whole family to adopt healthy living.</description>
    <arm_group_label>Intensive lifestyle modification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Waist circumference≥100cm OR HbA1c≥6.0%&#xD;
&#xD;
          -  South Asian, Male or Female, and age 40-70 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known type 1 or 2 diabetes&#xD;
&#xD;
          -  Fasting glucose≥7.0 mmol/L or HbA1c ≥6.5%&#xD;
&#xD;
          -  Normal or underweight (body mass index&lt;22kg/m2)&#xD;
&#xD;
          -  Pregnant or planning pregnancy&#xD;
&#xD;
          -  Unstable residence or planning to leave the area&#xD;
&#xD;
          -  Serious illness&#xD;
&#xD;
          -  Lack of capacity to consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Chambers, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Imperial College London</name>
      <address>
        <city>London</city>
        <zip>W2 1PG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 27, 2016</study_first_submitted>
  <study_first_submitted_qc>October 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2016</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Obesity, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Once the research is completed the data and results will be made fully anonymous (ie all personal information removed), and available for use by other researchers. Any remaining blood samples will be destroyed.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>2020</ipd_time_frame>
    <ipd_access_criteria>According to Study Protocol</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

